ITARECIPE is a multicenter national registry designed to study the diagnosis and evolution of Chronic Pancreatitis
Eligibility
Sex
ALL
Min age
12 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Age \>/= 12 years;
* Diagnosis "definite" or "probable" according to the "M-ANNHEIM" criteria;
* First evidence of diagnosis within 12 months of enrolment.
Exclusion Criteria:
* Age \< 12 years;
* History of known disease with certainty for \> 12 months.
Primary outcome measure(s)
Disease Progression — 5 years The collection of data on disease progression in terms of the need for medical, endoscopic or surgical therapy, the risk of pancreatic exo-endocrine failure and the risk of developing pancreatic and extrapancreatic complications and death.
Trial sites (1)
Facility
City
Region
Status
IRCCS Ospedale San Raffaele
Milan
Italy
Recruiting
More Associazione Italiana per lo Studio del Pancreas trials in Italy
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
